Crossmark

Fosfomycin, trimethoprim/sulfamethoxazole, or ciprofloxacin: which is better for infection prophylaxis with transrectal prostatic biopsy? Multicenter study

Crossref DOI link: https://doi.org/10.1186/s12301-025-00529-3

Published Online: 2025-09-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yousef, Ahmed

Kugler, Alexander

Hambaryan, Arman

Badawy, Hany F

Mohamed, Ahmed G.

Abd El Latif, Ahmed

Eladawy, Mahmoud Shoukry

Heikal, Samia

Abo Zamel, Ahmed

Gaber, Amr

Mohamed, Nassreldin

Ahmed, Huzaifa

Ismail, Hossam

Abdallah, Mahmoud

Ibrahim, Rabie M

Abdellatif, Heba

Mahmoud, Ossama
License Information

Text and Data Mining valid from 2025-09-26

Version of Record valid from 2025-09-26
More Information

Article History

Received: 27 June 2025

Accepted: 13 September 2025

First Online: 26 September 2025

Declarations

:

: Ethics committee approval was received for this study from the faculty of medicine, El Fayoum University Research Ethical Committee (REC) under the number 108/12–07-2023.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below